Strategic Overview of Patenting Activity in Pharma Sector of BRIC Countries

Patenting Trends, IP Policy Developments, and Strategic Insights

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

As developed markets are starting to witness slower growth rate; emerging markets, witnessing higher growth rate, are becoming key driver of revenue growth for multinational pharma companies. Much of this growth in Pharma sector of emerging markets is likely to be driven by BRIC, Mexico, and Turkey. This research service aims to highlight opportunities and risks in pharma sector of BRIC countries from a patenting perspective. This report also provides an overview of recent IP policy related developments and its business impact.

Table of Contents

Research ScopeExecutive SummaryResearch Background and IntroductionPatent applications Statistics for 2013*–Where BRIC Stands among Top 10?Research MethodologyPatent Search–Concepts, Scope and TimelineInternational Patent Classification (IPC) Codes Active Patent Stock of “Big Pharma” Companies in BRIC CountriesActive Patent Stock of “Big Pharma” Companies in BRICPatenting TrendsPharmaceuticals Sector–IndiaPatenting Activity at Indian Patent Office (IPO) in Pharma SectorTop 20 Patent Holders at Indian Patent Office (IPO), Pharma Sector, 2010- 2014Competitive Benchmarking of Top 20 Patent Holders Patent Publishing Trends at Indian Patent OfficePatenting Activity by Indian Inventors GloballyInventor Geographical Location: IndiaPatent Offices Coverage: GlobalTop 20 Patent Holders–Local and Foreign Filings by Indian InventorsPatent Office-Wise DistributionLocal and Foreign Filings by Indian Inventors10 Indian Pharma Companies–Patent Portfolio OverviewIP Policy Update: Recent Case Studies Case Study 1: Novartis vs. Cancer Patients Aid Association (CPAA)Case Study 1: Novartis vs. CPAANovartis vs. CPAA……..Continued.Novartis vs. CPAA……..Continued.Novartis vs. CPAA……..Continued.Novartis Case–Future Business ImplicationsCase Study 2: Bayer vs. NatcoCase Study 2 : Bayer vs. NatcoConditions for Compulsory Licensing (CL) in IndiaNatco’s Patent Protection for Nexavar -Time Line Bayer vs. Natco Case Study ……….ContinuedCompulsory Licensing to Natco in India –Future Business ImplicationsPatenting TrendsPharmaceuticals Sector–ChinaPatenting Activity at Chinese Patent Office (SIPO) in Pharma Sector Top 20 Patent Holders Chinese Patent Office (SIPO), Pharma Sector, 2010-14Patent Publishing Trends at SIPOPatenting activity by Chinese Inventors GloballyInventor Geographical Location: ChinaPatent Offices Coverage: GlobalTop 20 Patent Holders, Local and Foreign Filings by Chinese InventorsPatent Office-Wise DistributionYear-wise Patent Publishing Trends, Global10 Chinese Pharma Companies–Patent Portfolio OverviewNational Patent Development Strategy (2011-2020)Patent Quantity vs Quality Issue in ChinaIP Protection in ChinaPatenting TrendsPharmaceuticals Sector–BrazilPatenting Activity in Pharma Sector at Brazilian Patent Office (INPI)Top 20 Patent Holders at INPIPharma Sector, 2010-14Competitive Benchmarking of Top 20 Patent HoldersPatent Publishing Trends at INPIPatenting Activity by Brazilian Inventors GloballyInventor Geographical Location: BrazilPatent Offices Coverage: GlobalTop 20 Patent Holders, Local and Foreign Filings by Brazilian InventorsPatent Office-Wise DistributionYear-wise Patent Publishing Trends, GlobalPatent Backlog–A Big issue in BrazilPatenting Pharmaceutical Inventions in Brazil Compulsory Licensing in Brazil Patenting TrendsPharmaceuticals Sector–RussiaPatenting Activity in Pharma Sector at Russian Patent OfficeTop 20 Patent Holders at Russian Patent OfficePharma Sector, 2010-14Patent Publishing Trends at Russian Patent OfficeLegal DisclaimerAppendixAcronymsThe Frost & Sullivan StoryThe Frost & Sullivan StoryValue Proposition: Future of Your Company & CareerGlobal PerspectiveIndustry Convergence360º Research PerspectiveImplementation ExcellenceOur Blue Ocean Strategy




Keyword1

Keyword2

Keyword3

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.